State of Alaska Department of Revenue’s ADMA Biologics ADMA Stock Holding History

State of Alaska Department of Revenue’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.13M	Sell	134,910 -41,076	-23%	-$374K	0.01%	987
2026 Q1	$1.58M	Buy	175,986 +2,219	+1%	+$35K	0.02%	833
2025 Q4	$3.17M	Buy	173,767 +39,984	+30%	+$674K	0.03%	485
2025 Q3	$1.96M	Sell	133,783 -8,289	-6%	-$142K	0.02%	731
2025 Q2	$2.59M	Buy	142,072 +11,091	+8%	+$226K	0.03%	594
2025 Q1	$2.6M	Sell	130,981 -3,365	-3%	-$58.2K	0.03%	556
2024 Q4	$2.3M	Buy	134,346 +1,337	+1%	+$25.2K	0.03%	628
2024 Q3	$2.66M	Buy	+133,009	New	+$2.07M	0.03%	608

Other funds holding ADMA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

State of Alaska Department of Revenue's ADMA Position: Q2 2026 in Review

State of Alaska Department of Revenue reduced its ADMA Biologics (ADMA) stake by 23% in Q2 2026, selling an estimated $374K and leaving 134,910 shares worth $1.13M. The position accounts for 0.01% of the portfolio, ranked #987.

State of Alaska Department of Revenue first reported a position in ADMA in Q3 2024 and has held it in 8 quarters since. The position peaked at $3.17M in Q4 2025. 191 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

State of Alaska Department of Revenue held 134,910 shares of ADMA Biologics worth $1.13M as of Q2 2026.
State of Alaska Department of Revenue sold 41,076 ADMA Biologics shares in Q2 2026, an estimated $374K.
ADMA Biologics made up 0.01% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #987 holding.
State of Alaska Department of Revenue first reported a position in ADMA Biologics in Q3 2024 and has held it in 8 quarters since.
State of Alaska Department of Revenue's ADMA Biologics position peaked at $3.17M in Q4 2025.
191 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.